Minimally invasive surgery may offer safer option for early endometrial cancer
NCT ID NCT07514078
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study compares two surgical approaches for early-stage endometrial cancer: laparoscopic staging (minimally invasive) and open staging laparotomy (traditional open surgery). Researchers will enroll 30 patients to see if laparoscopy is as safe and effective as open surgery, with fewer complications and faster recovery. The goal is to determine if laparoscopy can be a standard alternative for treating early-stage endometrial cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- laparoscopic staging (a minimally invasive surgical procedure)
- What this could lead to
- If successful, this could show that laparoscopic staging is a safer and equally effective alternative to open surgery for early-stage endometrial cancer, leading to faster recovery and fewer complications.
- What could go wrong
- This is a small, early-phase study with only 30 participants, so results may not apply to all patients. There is also a risk of surgical complications like injury to organs or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital therapy aims to tame the fear that haunts cancer survivors
- Can a natural compound boost chemotherapy against endometrial cancer?
- Can a new nucleotide analogue boost cancer treatment?
- A remote diet and exercise program aims to help rural cancer survivors shed pounds and lower recurrence risk
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- Scientists probe hidden clues to immunotherapy success in endometrial cancer